BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19694715)

  • 1. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients.
    Eyrich M; Wiegering V; Lim A; Schrauder A; Winkler B; Schlegel PG
    Br J Haematol; 2009 Nov; 147(3):360-70. PubMed ID: 19694715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group.
    Ek T; Mellander L; Andersson B; Abrahamsson J
    Pediatr Blood Cancer; 2005 May; 44(5):461-8. PubMed ID: 15558707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment composition.
    van Tilburg CM; van der Velden VH; Sanders EA; Wolfs TF; Gaiser JF; de Haas V; Pieters R; Bloem AC; Bierings MB
    Leuk Res; 2011 Apr; 35(4):484-91. PubMed ID: 21051085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Moritz B; Eder J; Meister B; Heitger A
    Med Pediatr Oncol; 2001 Feb; 36(2):283-9. PubMed ID: 11452936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
    Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
    Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
    Scheid C; Pettengell R; Ghielmini M; Radford JA; Morgenstern GR; Stern PL; Crowther D
    Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up.
    van Tilburg CM; van Gent R; Bierings MB; Otto SA; Sanders EA; Nibbelke EE; Gaiser JF; Janssens-Korpela PL; Wolfs TF; Bloem AC; Borghans JA; Tesselaar K
    Br J Haematol; 2011 Jan; 152(2):201-10. PubMed ID: 21114483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation.
    Schlenke P; Sheikhzadeh S; Weber K; Wagner T; Kirchner H
    Bone Marrow Transplant; 2001 Aug; 28(3):251-7. PubMed ID: 11535992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children.
    Locatelli F; Maccario R; Comoli P; Bertolini F; Giorgiani G; Montagna D; Bonetti F; De Stefano P; Rondini G; Sirchia G; Severi F
    Bone Marrow Transplant; 1996 Dec; 18(6):1095-101. PubMed ID: 8971378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia.
    Poulsen A; Demeny AK; Bang Plum C; Gjerum Nielsen K; Schmiegelow K
    Med Pediatr Oncol; 2001 Jul; 37(1):20-3. PubMed ID: 11466718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic monitoring of maintenance therapy for acute lymphoblastic leukaemia in children-preliminary report.
    Luczynski W; Stasiak-Barmuta A; Krawczuk-Rybak M
    Pediatr Blood Cancer; 2004 May; 42(5):416-20. PubMed ID: 15049012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children].
    Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M
    Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
    El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
    Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.